Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review

CC Ngo, HM Massa, RB Thornton, AW Cripps - PloS one, 2016 - journals.plos.org
Background Otitis media (OM) is amongst the most common childhood diseases and is
associated with multiple microbial pathogens within the middle ear. Global and temporal …

Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era

R Kaur, M Morris, ME Pichichero - Pediatrics, 2017 - publications.aap.org
OBJECTIVES: To study the epidemiology of acute otitis media (AOM), especially the otitis-
prone condition, during the pneumococcal conjugate vaccines 7 and 13 era. METHODS: Six …

IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults

AW Chow, MS Benninger, I Brook… - Clinical infectious …, 2012 - academic.oup.com
Evidence-based guidelines for the diagnosis and initial management of suspected acute
bacterial rhinosinusitis in adults and children were prepared by a multidisciplinary expert …

Polymicrobial interaction in biofilm: mechanistic insights

A Kulshrestha, P Gupta - Pathogens and disease, 2022 - academic.oup.com
Polymicrobial biofilm (PMBF) formation during multispecies infection is a serious threat
growing worldwide. According to CDC, microbial biofilm infection covers more than 65% of …

A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera

R Lappan, K Imbrogno, C Sikazwe, D Anderson… - BMC microbiology, 2018 - Springer
Background Recurrent acute otitis media (rAOM, recurrent ear infection) is a common
childhood disease caused by bacteria termed otopathogens, for which current treatments …

COVID-19 pandemic impact on respiratory infectious diseases in primary care practice in children

R Kaur, S Schulz, N Fuji, M Pichichero - Frontiers in Pediatrics, 2021 - frontiersin.org
Background: The coronavirus disease 2019 (COVID-19) pandemic led to day care and
school closures and children staying home for several months. When they gradually …

Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young …

M Pichichero, R Kaur, DA Scott, WC Gruber… - The Lancet Child & …, 2018 - thelancet.com
Background With wide use of the seven-valent pneumococcal conjugate vaccine (PCV7) for
protection against acute otitis media caused by Streptococcus pneumoniae serotypes …

Predominance of nontypeable Haemophilus influenzae in children with otitis media following introduction of a 3+ 0 pneumococcal conjugate vaccine schedule

SP Wiertsema, LAS Kirkham, KJ Corscadden… - Vaccine, 2011 - Elsevier
In Australia the 7-valent pneumococcal conjugate vaccine (PCV7) is administered at 2, 4
and 6 months of age, with no booster dose. Information on bacterial carriage and the …

Acute otitis media in children—challenges of antibiotic resistance in the post-vaccination era

C Gavrilovici, EL Spoială, IC Miron, IM Stârcea… - Microorganisms, 2022 - mdpi.com
Acute otitis media (AOM) is a leading cause of antibiotic prescriptions in children worldwide,
even in the era of pneumococcal conjugate vaccines. We aimed to assess the bacterial …

Public health impact and cost-effectiveness of 15-valent pneumococcal conjugate vaccine use among the pediatric population of the United States

N Prasad, C Stoecker, W Xing, BH Cho, AJ Leidner… - Vaccine, 2023 - Elsevier
Background Although use of the 13-valent pneumococcal conjugate vaccine (PCV13)
among children has reduced incidence of pneumococcal disease, a considerable burden of …